Molecules · 2019 · 17 citations · 11 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular OncologyTumor MicroenvironmentAntitumor T Cell ResponsesCancer ImmunotherapyOncology PharmacologyTumor Microenvironment ModulationAngiogenesis In Tumor PromotionAntitumor Immune ActivationCell Cycle InhibitionImmune System ModulationImmune Tolerance RestorationMolecularly Targeted AgentsTh1 Immune ResponseTh1 Responses
Tumor cells have specific features, including angiogenesis induction, cell cycle dysregulation, and immune destruction evasion. By inducing a T helper type 2 (Th2) immune response, tumor cells may favor immune tolerance within the tumor, which allows progression of cancer growth. Drugs with potential antitumor activity are the spiro-acridines, which is a promising new class of acridine compounds. Herein, the novel spiro-acridine (E)-5′-oxo-1′-((3,4,5-trimethoxybenzylidene)amino)-1′,5′-dihydro-10H-spiro[acridine-9,2′-pyrrole]-4′-carbonitrile (AMTAC-17) was synthesized and tested for antitumor effects. Toxicity evaluation was performed in mice after acute treatment (2000 mg/kg, intraperitoneally, i.p.). The Ehrlich ascites carcinoma model was used to investigate the antitumor activity of AMTAC-17 (12.5, 25, or 50 mg/kg, i.p.) after seven days of treatment. Effects on the cell cycle, angiogenesis, and inflammatory responses were investigated. LD50 (lethal dose 50%) was estimated to be higher than 5000 mg/kg. AMTAC-17 reduced the Ehrlich tumor’s total viable cancer cells count and peritumoral micro-vessels density, and induced an increase in the sub-G1 peak. Additionally, there was an increase of Th1 cytokine profile levels (IL-1β, TNF-α, and IL-12). In conclusion, the spiro-acridine compound AMTAC-17 presents low toxicity, and its in vivo antitumor effect involves modulation of the immune system to a cytotoxic Th1 profile and a reduction of tumor angiogenesis.
11
Sinara Mônica Vitalino de Almeida, Elizabeth Almeida Lafayette, Willams Leal Silva et al. · International Journal of Biological Macromolecules · 2016 · 46 citations
Rawny Galdino Gouveia, Amélia Galdino Ribeiro, Miguel Ângelo Santos Pinheiro Segundo et al. · Bioorganic & Medicinal Chemistry · 2018 · 38 citations
Tumor Regression and Cure Depends on Sustained Th1 Responses
Min Dai, Ingegerd Hellström, Yuen Yee Yip et al. · Journal of Immunotherapy · 2018 · 37 citations · Full text
Life Sciences, Immunology, Oncology +17